MetaCap

10x Genomics Statistics

NASDAQ: TXGIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD

51.80-5.58 (-9.72%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

10x Genomics by the numbers

10x Genomics has a market capitalization of $6.81 billion based on 121.46M shares outstanding. With trailing EPS of $-0.52, 10x Genomics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.9% below its 50-day average and 19.1% above its 200-day average.

Average daily trading volume is 3.36M shares, or about $173.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

TXG valuation vs. peer median

TXG compared with the median of 8 peer companies
MetricTXGPeer medianDifference
Market cap$6.81B$1.32B+416%
Avg. volume3.36M1.82M+85%

Peer median across 8 companies: BRKR, BIO, AVTR, ALMR, CTKB, PACB, NAUT, LAB.

Valuation

Price / sales (latest FY)
10.60
EPS (TTM)
$-0.52

Price and trading

Previous close
57.38
Open
56.44
Day range
51.30 – 56.44
52-week range
15.18 – 102.81
52-week change
+182.44%
Beta
—
Volume
3.23M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
6.81B
Forward Pe
597.67
Eps
-0.52
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
102.81
Week52 Low
15.18
Avg Volume
3.36M
Shares Outstanding
121.46M
Ma50
72.86
Ma200
43.49
Earnings Date
Nov 5, 2026
Pct From52w High
-49.62%
Pct From52w Low
241.24%

Related